Palisade Bio (PALI) Capital Expenditures (QoQ) (2010 - 2020)
Powered by 
Analysis
Palisade Bio (PALI) Capital Expenditures (QoQ) (2010 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 200.00% |
| Jun 30, 2019 | -17.02% |
| Mar 31, 2019 | -736.61% |
| Mar 31, 2018 | 880.39% |
| Dec 31, 2017 | -69.07% |
| Sep 30, 2017 | -86.14% |
| Jun 30, 2017 | 5,884.28% |
| Jun 30, 2016 | 471.93% |
| Mar 31, 2016 | -69.62% |
| Dec 31, 2015 | 49.28% |
| Sep 30, 2015 | -59.74% |
| Jun 30, 2015 | 398.17% |
| Mar 31, 2015 | -55.06% |
| Dec 31, 2014 | 31.91% |
| Sep 30, 2014 | -20.36% |
| Jun 30, 2014 | -69.39% |
| Mar 31, 2014 | 1,629.25% |
| Dec 31, 2013 | -94.34% |
| Sep 30, 2013 | 2,939.24% |
| Jun 30, 2013 | 125.60% |